| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |